Recombinant Human CD269/TNFRSF17/BCMA Protein, C-His
Overview
| Catalog No. |
HX959031 |
| Form |
Lyophilized |
| Storage buffer |
Lyophilized from a solution in PBS pH 7.4, 1 mM EDTA, 4% Trehalose, 1% Mannitol. |
| Purity |
>90% as determined by SDS-PAGE. |
| Applications |
ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress |
| Endotoxin level |
Please contact with the lab for this information. |
| Expression system |
Mammalian Cells |
| Accession |
Q02223 |
| Protein length |
Leu2-Ala54 |
| Nature |
Recombinant |
| Predicted molecular weight |
9.18 kDa |
| Stability and Storage |
Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt. |
| Reconstitution |
Reconstitute in sterile water for a stock solution.A copy of datasheet will be provided with the products, please refer to it for details. |
| Alternative name | Tumor necrosis factor receptor superfamily member 17, B-cell maturation protein, CD269, TNFRSF17, BCM, BCMA |
| Species |
Homo sapiens (Human) |
| Shipping |
In general, proteins are provided as lyophilized powder/frozen liquid. They are shipped out with dry ice/blue ice unless customers require otherwise. |
| Note |
For research use only. |
Images
 Bioactivity |
Detects Alnuctamab in indirect ELISAs. |
 Bioactivity |
Detected by Research Grade Linvoseltamab (Cat No.: HX959086) in indirect ELISA. |